CN101260048A - Method for preparing rasagiline - Google Patents

Method for preparing rasagiline Download PDF

Info

Publication number
CN101260048A
CN101260048A CNA2008100236199A CN200810023619A CN101260048A CN 101260048 A CN101260048 A CN 101260048A CN A2008100236199 A CNA2008100236199 A CN A2008100236199A CN 200810023619 A CN200810023619 A CN 200810023619A CN 101260048 A CN101260048 A CN 101260048A
Authority
CN
China
Prior art keywords
under
suitable solvent
compound
rasagiline
following material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2008100236199A
Other languages
Chinese (zh)
Inventor
沈宗旋
张燕飞
肖本良
倪燕华
倪春华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SUZHOU CHIREACH BIOMEDICAL TECHNOLOGY Co Ltd
Original Assignee
SUZHOU CHIREACH BIOMEDICAL TECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SUZHOU CHIREACH BIOMEDICAL TECHNOLOGY Co Ltd filed Critical SUZHOU CHIREACH BIOMEDICAL TECHNOLOGY Co Ltd
Priority to CNA2008100236199A priority Critical patent/CN101260048A/en
Publication of CN101260048A publication Critical patent/CN101260048A/en
Pending legal-status Critical Current

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention discloses a preparation method for rasagiline. The steps of the method is as follows: firstly 1-indone is taken as starting materials, and added in with chiral auxiliary reagents and reacted in solvents, obtaining compounds(II); secondly, under a certain condition, compounds(II) obtained are reduced in proper solvents for obtaining compounds(III); thirdly, under a certain temperature and in a certain solvent, compounds(III) obtained undergo the actions of alkali and acid for obtaining compounds(IV); fourthly, under a certain temperature and in a certain solvent, compounds(IV) obtained are filled with HCI gases, obtaining compounds(V); fifthly under a certain temperature and in a certain solvent, compounds(V) obtained react with 3- propargyl bromide under the action of alkali so as to obtain compounds(VI); finally, under a certain temperature and in a certain solvent, compounds(VI) obtained are dropwise added with methanesulfonic acid to obtain the rasagiline(VII). The method of the invention has the advantages of simple operation, low cost, high yield and little pollution, and is suitable for the industrialized production.

Description

The preparation method of rasagiline
Technical field
The present invention relates to a kind of preparation method of rasagiline, relate in particular to a kind of preparation method who is used for Mirapexin thing rasagiline.
Background technology
Rasagiline (rasagiline) is a kind of Mirapexin thing.It is the Irreversible selective oxidase inhibitor, belong to the irreversible monoamine oxidase beta inhibitor of the s-generation, compare with previous propargyl amine monoamine oxidase beta inhibitor (as selegiline), it is strong to have effect, can not produce the advantages such as metabolite of amphetamine.In addition by board of consultants of European medicine assessment administration as early stage Parkinsonian's initial single medical service law and in to severe patient's adjuvant therapy, can significantly improve motor symptom and quality of life, can also significantly reduce the illness motion anergy in late period, compare with other treatment Parkinson's disease medicine, the incidence of its toxic side effect is lower.In addition, this medicine is at present also in the clinical study that is used for the treatment of senile dementia (A D), dysthymia disorders, childhood hyperkinetic syndrome.
Summary of the invention
The preparation method who the purpose of this invention is to provide a kind of rasagiline, this method has advantages such as easy and simple to handle, that cost is lower, yield is higher, pollution is less, is suitable for the suitability for industrialized production needs more.
Technical scheme of the present invention is: the preparation method of a kind of rasagiline (R)-N-2-Propynyl-1-indanaminemethanesulfonate may further comprise the steps:
(1) with the 1-indone
Figure A20081002361900041
Be starting raw material, under 50-150 ℃ temperature condition, introduce chiral auxiliary(reagent), reaction obtains compound (II) in suitable solvent; Described solvent comprises at least a in the following material: ethyl acetate, methyl alcohol, ethanol, benzene, toluene, isopropyl acetate, isobutyl acetate;
Figure A20081002361900042
(2) with the compound (II) that obtains in the step (1), under temperature 0-50 ℃, pressure 0-50atm condition, reduction obtains compound (III) in suitable solvent; Described suitable solvent comprises at least a in the following material: ethyl acetate, methyl alcohol, ethanol, benzene, toluene;
(3), under 50-100 ℃ of temperature condition and in the suitable solvent, under the effect of alkali and acid, obtain compound (IV) with the compound (III) that obtains in the step (2); Described suitable solvent comprises at least a in the following material: ethyl acetate, methyl alcohol, ethanol, benzene, toluene, tetrahydrofuran (THF);
(4) with the compound (IV) that obtains in the step (3), under-20-20 ℃ temperature condition and in the suitable solvent, feed HCl gas, obtain compound (V); Described suitable solvent comprises at least a in the following material: ethyl acetate, methylene dichloride, chloroform, normal hexane;
(5), under 0-30 ℃ of temperature condition and in the suitable solvent, under the effect of alkali, obtain compound (VI) with the reaction of 3-propargyl bromide with the compound (V) that obtains in the step (4); Described suitable solvent comprises at least a in the following material: methylene dichloride, ethyl acetate, methyl alcohol, ethanol, tetrahydrofuran (THF), acetonitrile;
(6), under 0-50 ℃ of temperature condition, and in the suitable solvent, drip methanesulfonic and obtain rasagiline (VII) with the compound (VI) that obtains in the step (5); Described suitable solvent comprises at least a in the following material: ethyl acetate, methyl alcohol, ethanol, ether, isopropyl ether.
Figure A20081002361900055
The further technical scheme of the present invention is: a kind of preparation method of rasagiline, and described rasagiline is the Chiral Amine compounds with following structure formation:
Figure A20081002361900061
May further comprise the steps:
(1) with the 1-indone Be starting raw material, under 50-150 ℃ temperature condition, best 80-120 ℃, introduce chiral auxiliary(reagent), reaction obtains compound (II) in suitable solvent; Described solvent comprises at least a in the following material: ethyl acetate, methyl alcohol, ethanol, benzene, toluene, isopropyl acetate, isobutyl acetate; Described chiral auxiliary(reagent) comprises at least a in the following material: chiral amino acid, chiral amino alcohol, the glycol of chirality, the acid amides of chirality, the amine of chirality, the carboxylic acid of chirality;
Figure A20081002361900063
(2) with the compound (II) that obtains in the step (1), under temperature 0-50 ℃, pressure 0-50atm condition, optimum temperature range 0-30 ℃, pressure range 1-10atm; Reduction obtains compound (III) in suitable solvent; Described suitable solvent comprises at least a in the following material: ethyl acetate, methyl alcohol, ethanol, benzene, toluene;
Figure A20081002361900064
(3), under 50-100 ℃ of temperature condition and in the suitable solvent, under the effect of alkali and acid, obtain compound (IV) with the compound (III) that obtains in the step (2); Described suitable solvent comprises at least a in the following material: ethyl acetate, methyl alcohol, ethanol, benzene, toluene, tetrahydrofuran (THF); Described alkali can be mineral alkali, also can be organic bases, or both are with a certain proportion of combination, and it can comprise at least a in the following material: sodium hydroxide, yellow soda ash, sodium bicarbonate, triethylamine; Described acid comprises at least a in the following material: hydrochloric acid, phosphorus trichloride;
(4) with the compound (IV) that obtains in the step (3), under-20-20 ℃ temperature condition and in the suitable solvent, feed HCl gas, obtain compound (V); Described suitable solvent comprises at least a in the following material: ethyl acetate, methylene dichloride, chloroform, normal hexane;
Figure A20081002361900071
(5) with the compound (V) that obtains in the step (4), under 0-30 ℃ of temperature condition, best 20-30 ℃, and in the suitable solvent, under the effect of alkali, obtain compound (VI) with the reaction of 3-propargyl bromide; Described suitable solvent comprises at least a in the following material: methylene dichloride, ethyl acetate, methyl alcohol, ethanol, tetrahydrofuran (THF), acetonitrile; Described alkali comprises at least a in the following material: sodium hydroxide, potassium hydroxide, yellow soda ash, salt of wormwood, triethylamine;
Figure A20081002361900072
(6) with the compound (VI) that obtains in the step (5), under 0-50 ℃ of temperature condition, best 20-30 ℃, and in the suitable solvent, drip methanesulfonic and obtain rasagiline (VII); Described suitable solvent comprises at least a in the following material: ethyl acetate, methyl alcohol, ethanol, ether, isopropyl ether.
Figure A20081002361900073
The synthetic route of rasagiline of the present invention (VII) is as follows:
Figure A20081002361900074
Specifically be divided into:
Advantage of the present invention is:
1. synthesis technique of the present invention is selected rationally, and is simple to operate, need not to carry out complicated fractionation and purifying, reduced production cost.
2. raw material sources of the present invention are convenient, and the chemical yield height of product, optical purity height pollute lessly, are suitable for suitability for industrialized production.
Embodiment
Below in conjunction with embodiment the present invention is further described:
Embodiment:
1. the preparation of compound (II)
In the 100mL round-bottomed flask, add (S)-phenylethylamine (8.24g, 0.068mol), the 1-indone (9.79g, 1.1equiv), one hydration tosic acid (0.65g, 5mol%), the 50mL isopropyl acetate installs water-and-oil separator, backflow 6h, be cooled to room temperature, continue to stir 3h, filter and obtain white solid; Then the solid that obtains is dissolved in the 50mL water and stirs 5min, filter, use 15mL water, 15mL * 2 isopropyl acetates washing successively, obtain compound (II) 13.2g, productive rate 82.5%.
2. the preparation of compound (III)
Add compound (II) (13.2g in the 1L autoclave, 0.056mol), 200mL isopropyl acetate, 15g (125w/w%) Raney's nickel (using 50mL * 2 methyl alcohol, 50mL * 2 isopropyl acetate washed twice successively), at 3.5bar H2,40 ℃ of reaction 45h, filter, and with 300mL isopropyl acetate washing filter residue, obtain compound (III) 11.71g, productive rate 88% after concentrating the removal solvent.
3. the preparation of compound (IV)
Add (4.94g, 0.0208mol) compound (III), 75mL THF, the Et of 35mL (12equiv) in the 250mL round-bottomed flask 3N, put then with ice-water bath in be chilled to 0 ℃, drip (5.5mL, 2.2equiv) PCl 5, add the back and continue under ice bath, to stir 15min, stir 1h under the room temperature, the 5h that refluxes then is cooled to room temperature, adds NH 2The aqueous solution of OHHCl (4.34g NH 2OHHCl, 3equiv is dissolved in the 75mL water), continue to stir 16h under the room temperature, concentrate and remove THF, drip 30% hydrochloric acid conditioning solution pH=1 (needing 20mL approximately), (2 * 75mL) washed twice add 100mLCH then with methyl tertiary butyl ether 2Cl 2, regulate pH=9 (needing 25mL approximately) with 33%NaOH solution, tell CH 2Cl 2Layer, anhydrous sodium sulfate drying obtains compound (IV) 1.94g, productive rate 70% after concentrating.
4. the preparation of compound (V)
Add in the 250mL round-bottomed flask (1.94g, 0.0146mol) compound (IV) add the 100mL ethyl acetate, put then with ice-water bath in be chilled to 0 ℃, feed HCl gas, filter and obtain compound (V) 2.43g, productive rate 98%.
5. the preparation of compound (VI) and compound (VII)
In the three-necked flask of a 2L; hydrochloride (compound (V)) (20g that adds the amino indenes of 1-; 117.89mmol); salt of wormwood (32.59g; 235.78mmol) and the acetonitrile of 800mL, be heated to 60 ℃ under the nitrogen protection and refluxed 2 hours, behind the cool to room temperature; slowly drip acetonitrile (100mL) solution of 3-propargyl bromide (18.02g), about 20min drips off.After the system stirring at room 24 hours, filter, filtrate evaporate to dryness, residuum join in 400mL water and the 400mL toluene, and the hydrochloric acid with 20% is regulated PH=4.Separatory, water afterwards, is removed toluene layer with toluene extraction (200mL * 3).Water is regulated PH=8 with 10% sodium hydroxide, and with toluene extraction (200mL * 5), combining methylbenzene layer, anhydrous sodium sulfate drying concentrates and obtains flaxen liquid, and compound (VI) (13.1g).In this liquid, add anhydrous diethyl ether 600mL, slowly drip the anhydrous ether solution (8.2g of methanesulfonic under the churned mechanically situation, 100mL) anhydrous diethyl ether, about 30min drips off, and continues to stir the 2h after-filtration, and filter cake washs with anhydrous diethyl ether, obtain the white solid crude product, purify through the Virahol recrystallization, obtain compound (VII) 20.04g, productive rate 63.6%.
mp:156-158℃,[α]20D=+22.5°(c=1,C 2H 5OH)。
Easy and simple to handle, the advantages such as cost is lower, yield is higher, less pollution that the inventive method has, more Be suitable for the suitability for industrialized production needs.

Claims (8)

1. the preparation method of a rasagiline is characterized in that may further comprise the steps:
(1) with the 1-indone
Figure A20081002361900021
Be starting raw material, under 50-150 ℃ temperature condition, introduce chiral auxiliary(reagent), reaction obtains compound (II) in suitable solvent; Described solvent comprises at least a in the following material: ethyl acetate, methyl alcohol, ethanol, benzene, toluene, isopropyl acetate, isobutyl acetate;
(2) with the compound (II) that obtains in the step (1), under temperature 0-50 ℃, pressure 0-50atm condition, reduction obtains compound (III) in suitable solvent; Described suitable solvent comprises at least a in the following material: ethyl acetate, methyl alcohol, ethanol, benzene, toluene, tetrahydrofuran (THF);
Figure A20081002361900023
(3), under 50-100 ℃ of temperature condition and in the suitable solvent, under the effect of alkali and acid, obtain compound (IV) with the compound (III) that obtains in the step (2); Described suitable solvent comprises at least a in the following material: ethyl acetate, methyl alcohol, ethanol, benzene, toluene, tetrahydrofuran (THF);
Figure A20081002361900024
(4) with the compound (IV) that obtains in the step (3), under-20-20 ℃ temperature condition and in the suitable solvent, feed HCl gas, obtain compound (V); Described suitable solvent comprises at least a in the following material: ethyl acetate, methylene dichloride, chloroform, normal hexane;
Figure A20081002361900025
(5), under 0-30 ℃ of temperature condition and in the suitable solvent, under the effect of alkali, obtain compound (VI) with the reaction of 3-propargyl bromide with the compound (V) that obtains in the step (4); Described suitable solvent comprises at least a in the following material: methylene dichloride, ethyl acetate, methyl alcohol, ethanol, tetrahydrofuran (THF), acetonitrile;
Figure A20081002361900031
(6), under 0-50 ℃ of temperature condition and in the suitable solvent, drip methanesulfonic and obtain rasagiline (VII) with the compound (VI) that obtains in the step (5); Described suitable solvent comprises at least a in the following material: ethyl acetate, methyl alcohol, ethanol, ether, isopropyl ether.
2. according to the preparation method of the described rasagiline of claim 1, it is characterized in that: chiral auxiliary(reagent) described in the step (1) comprises at least a in the following material: chiral amino acid, chiral amino alcohol, the glycol of chirality, the acid amides of chirality, the amine of chirality, the carboxylic acid of chirality.
3. according to the preparation method of the described rasagiline of claim 1, it is characterized in that: being reflected under the 80-120 ℃ of temperature condition in the step (1) carried out.
4. according to the preparation method of the described rasagiline of claim 1, it is characterized in that: be reflected at temperature range 0-30 ℃ in the step (2), carry out under the pressure range 1-10atm.
5. according to the preparation method of the described rasagiline of claim 1, it is characterized in that: the alkali described in the step (3) comprises at least a in the following material: sodium hydroxide, yellow soda ash, sodium bicarbonate, triethylamine; Described acid comprises at least a in the following material: hydrochloric acid, phosphorus trichloride.
6. according to the preparation method of the described rasagiline of claim 1, it is characterized in that: being reflected under the 20-30 ℃ of temperature condition in the step (5) carried out.
7. according to the preparation method of the described rasagiline of claim 1, it is characterized in that: the alkali described in the step (5) comprises at least a in the following material: sodium hydroxide, potassium hydroxide, yellow soda ash, salt of wormwood, triethylamine.
8. according to the preparation method of the described rasagiline of claim 1, it is characterized in that: being reflected under the 20-30 ℃ of temperature condition in the step (6) carried out.
CNA2008100236199A 2008-04-15 2008-04-15 Method for preparing rasagiline Pending CN101260048A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNA2008100236199A CN101260048A (en) 2008-04-15 2008-04-15 Method for preparing rasagiline

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNA2008100236199A CN101260048A (en) 2008-04-15 2008-04-15 Method for preparing rasagiline

Publications (1)

Publication Number Publication Date
CN101260048A true CN101260048A (en) 2008-09-10

Family

ID=39960783

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2008100236199A Pending CN101260048A (en) 2008-04-15 2008-04-15 Method for preparing rasagiline

Country Status (1)

Country Link
CN (1) CN101260048A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009122301A3 (en) * 2008-03-31 2009-11-26 Actavis Group Ptc Ehf Rasagiline mesylate particles and process for the preparation thereof
CN102010353A (en) * 2010-10-22 2011-04-13 湖北能特科技股份有限公司 New method for preparing rasagiline mesylate
WO2011048612A2 (en) * 2009-10-14 2011-04-28 Glenmark Generics Limited Processes for the preparation of propargylated aminoindans or a pharmaceutically acceptable salt thereof
CN102154432A (en) * 2010-12-20 2011-08-17 蚌埠丰原医药科技发展有限公司 Method for preparing rasagiline
CN109180499A (en) * 2018-07-31 2019-01-11 上海博志研新药物技术有限公司 The preparation method of rasagiline mesilate and its intermediate
CN110229067A (en) * 2019-06-05 2019-09-13 南京焕然生物科技有限公司 A kind of 2- amino indenes preparation method
CN110615747A (en) * 2018-06-20 2019-12-27 广东东阳光药业有限公司 Preparation method of indane intermediate
CN111333517A (en) * 2018-12-19 2020-06-26 上海奥博生物医药技术有限公司 Improved method for preparing rasagiline

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009122301A3 (en) * 2008-03-31 2009-11-26 Actavis Group Ptc Ehf Rasagiline mesylate particles and process for the preparation thereof
WO2011048612A2 (en) * 2009-10-14 2011-04-28 Glenmark Generics Limited Processes for the preparation of propargylated aminoindans or a pharmaceutically acceptable salt thereof
WO2011048612A3 (en) * 2009-10-14 2011-08-11 Glenmark Generics Limited Process for preparation of propargylated aminoindans or pharmaceutically acceptable salts thereof
CN102010353A (en) * 2010-10-22 2011-04-13 湖北能特科技股份有限公司 New method for preparing rasagiline mesylate
CN102154432A (en) * 2010-12-20 2011-08-17 蚌埠丰原医药科技发展有限公司 Method for preparing rasagiline
CN102154432B (en) * 2010-12-20 2013-06-12 蚌埠丰原医药科技发展有限公司 Method for preparing rasagiline
CN110615747A (en) * 2018-06-20 2019-12-27 广东东阳光药业有限公司 Preparation method of indane intermediate
CN109180499A (en) * 2018-07-31 2019-01-11 上海博志研新药物技术有限公司 The preparation method of rasagiline mesilate and its intermediate
CN109180499B (en) * 2018-07-31 2021-04-30 上海博志研新药物技术有限公司 Preparation method of rasagiline mesylate and intermediate thereof
CN111333517A (en) * 2018-12-19 2020-06-26 上海奥博生物医药技术有限公司 Improved method for preparing rasagiline
CN110229067A (en) * 2019-06-05 2019-09-13 南京焕然生物科技有限公司 A kind of 2- amino indenes preparation method

Similar Documents

Publication Publication Date Title
CN101260048A (en) Method for preparing rasagiline
CN102438982B (en) Methods and intermediates for preparing cytochrome P450 monooxygenase inhibitor
EP1820792B1 (en) Process for the preparation of adamantanamines
CN101654445B (en) Compound for preparing ramelteon, preparation method thereof and application thereof
AU2007274034B2 (en) Process of preparing a gamma-amino acid
US20040106818A1 (en) Process for the preparation of cyclohexanol derivatives
JP6292124B2 (en) Method for producing carbamate compound
CN101654419A (en) Preparation method of fluvoxamine maleate
CN101939289A (en) Novel process for the preparation of vorinostat
CN101531654A (en) Preparation method for Rupatadine
EP2114862A1 (en) Process for the preparation of o-desmethyl venlafaxine
CN100410235C (en) Capsicine chemical synthesis and purification method
CN100427460C (en) Method for synthesis of L-norvaline
CN103288699A (en) Preparation method of proline analogue
CN102838511A (en) Sitagliptin intermediates as well as preparation method and application of intermediate
CN102164886A (en) Process for the preparation of O-desmethylvenlafaxine
CN102010353A (en) New method for preparing rasagiline mesylate
KR20090123047A (en) Novel method for preparing itopride and the intermediate obtained from the method
CN101265201B (en) Method for synthesizing tramadol hydrochloride
CN1310940C (en) Process for producing triterpene derivative
KR101830693B1 (en) Process for Preparing Treprostinil and Intermediate Therefor
CN1266116C (en) Venlafaxine and its salt preparing method
KR100368896B1 (en) A process for preparing 6-aminomethyl-5H-dibenz[b,e]azepine
CN101511771A (en) A process for producing [(4,4- dif luorocyclohexyl) methyl] amine
JP2015137255A (en) Method for producing carbamate compound

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20080910